谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

P740: PK, PD AND SAFETY OF FIRST-IN-HUMAN, FIRST-IN-CLASS PHASE I TRIAL (AUR103-101; BHARAT) OF AUR103, AN ORAL CD47 INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES

Manjunath Krishnappa, Divyesh Mandavia,Minish Jain, Mukesh S,Ankit Patel, Anshul Agarwal,Sanjeev Giri,Nirbhay Kumar Tiwari,Saravanan Thiyagarajan,Mamon Dey, Gutta Padmanabha Naidu,Murali Ramachandra, Akhil Kumar

HemaSphere（2023）

引用 1|浏览7
关键词
CD47
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要